NDUFA2 and ovarian carcinoma: This 2.9 kb deletion overlaps the gene ITGB8, which encodes the cell-surface glycoprotein β8 integrinITGB8a is a  well-established drug target for ovarian cancer and its expression is critical for dendritic cell-mediated induction of regulatory T-cell repertoires44.